These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 9461702)

  • 1. [Efficacy of mononitrate retard therapy in patients with advanced congestive heart failure].
    Chmielewski M; Mamcarz A; Dłuzniewski M; Braksator W; Król J; Krysztofiak H; Kuch M; Beranek G
    Pol Merkur Lekarski; 1997 Sep; 3(15):101-4. PubMed ID: 9461702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Functional activity of platelet guanylate cyclase and cardiac hemodynamics in patients with chronic heart failure and relevant changes after treatment with isosorbide-5-mononitrate].
    Ol'binskaia LI; Ushakova AV; Sizova ZhM
    Ter Arkh; 1999; 71(9):77-9. PubMed ID: 10553632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of isosorbide-5-mononitrate on exercise performance and clinical status in patients with congestive heart failure. Results of the Nitrates in Congestive Heart Failure (NICE) Study.
    Lewis BS; Rabinowitz B; Schlesinger Z; Caspi A; Markiewicz W; Rosenfeld T; Sclarovsky S; Ermer W
    Cardiology; 1999; 91(1):1-7. PubMed ID: 10393392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isosorbide Mononitrate in Heart Failure with Preserved Ejection Fraction.
    Redfield MM; Anstrom KJ; Levine JA; Koepp GA; Borlaug BA; Chen HH; LeWinter MM; Joseph SM; Shah SJ; Semigran MJ; Felker GM; Cole RT; Reeves GR; Tedford RJ; Tang WH; McNulty SE; Velazquez EJ; Shah MR; Braunwald E;
    N Engl J Med; 2015 Dec; 373(24):2314-24. PubMed ID: 26549714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cardiological use of mononitrates].
    Gurevich MA; Sanina NP; Buval'tsev VI
    Klin Med (Mosk); 2000; 78(4):44-8. PubMed ID: 10833891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparison of the effectiveness of olicard 40 retard and cardonit 40 prolongatum preparations in treatment of stable coronary heart disease].
    Kurpesa M; Krzemińska-Pakuła M; Kedzia E; Trzos E; Musiał W; Peruga Z
    Wiad Lek; 1994 Aug; 47(15-16):587-90. PubMed ID: 7716955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversal of heart failure remodeling in women.
    Levine TB; Levine AB; Kaminski P; Stomel RJ
    J Womens Health Gend Based Med; 2000 Jun; 9(5):513-9. PubMed ID: 10883943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative clinical trial of isosorbide 5-mononitrate and sustained-release isosorbide dinitrate in ischaemic heart disease.
    Neuhaus R; Johnen R; Vydra L; Solbach C
    Pharmatherapeutica; 1986; 4(8):486-95. PubMed ID: 3086899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The therapeutic and prophylactic use of Olicard-Retard under outpatient polyclinical conditions in stenocardia patients].
    Mikhaĭlusova MP; Bart BIa; Kulikov SI; Smirnova OL; Anchipolovskaia NG; Mamtsev BN; Dergunova EN
    Ter Arkh; 1997; 69(1):17-20. PubMed ID: 9163041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Anti-ischemic efficacy of sustained-release isosorbide-5-mononitrate: echocardiography during mental and physical stress].
    Keck M; Tretter R; Sauerbrey-Wullkopf N
    Z Kardiol; 2001 Oct; 90(10):766-73. PubMed ID: 11757473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antianginal and anti-ischemic efficacy of nicorandil in comparison with isosorbide-5-mononitrate and isosorbide dinitrate: results from two multicenter, double-blind, randomized studies with stable coronary heart disease patients.
    Döring G
    J Cardiovasc Pharmacol; 1992; 20 Suppl 3():S74-81. PubMed ID: 1282180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Isosorbide-5-mononitrate in silent ischemia].
    Pichler M; Brandt D; Teubl H; Dorda W
    Wien Klin Wochenschr; 1995; 107(13):390-5. PubMed ID: 7638969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Lack of tolerance after administration of delayed-action isosorbide-5-mononitrate for 3 days in patients with exercise-induced silent ischemia: control with placebo].
    Scardi S; Pandullo C; Humar F; Spanghero M; Mazzone C
    G Ital Cardiol; 1992 May; 22(5):549-57. PubMed ID: 1426792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The anti-anginal efficacy of the drug forms of isosorbide-5-mononitrate--Monocinque, Monocinque retard and isosorbide dinitrate].
    Chernov SA; Tiurin VP; Gospodarenko AL; Kutepov IuS; Virs EA; Malenik OM
    Voen Med Zh; 1997 Apr; 318(4):39-41. PubMed ID: 9221593
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study.
    Cohn JN; Archibald DG; Ziesche S; Franciosa JA; Harston WE; Tristani FE; Dunkman WB; Jacobs W; Francis GS; Flohr KH
    N Engl J Med; 1986 Jun; 314(24):1547-52. PubMed ID: 3520315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of isosorbide-5-mononitrate versus nifedipine in preventing spontaneous and ergonovine-induced myocardial ischaemia. A double-blind, placebo-controlled study.
    Lombardi M; Morales MA; Michelassi C; Moscarelli E; Distante A; L'Abbate A
    Eur Heart J; 1993 Jun; 14(6):845-51. PubMed ID: 8325315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Endothelial dysfunction in patients with chronic heart failure, and possibilities of its correction with isosorbide-5-mononitrates].
    Ol'binskaia LI; Sizova ZhM; Kolbaia NG
    Klin Med (Mosk); 2007; 85(1):27-31. PubMed ID: 17419351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of isosorbide-5-mononitrate on exercise capacity, prostacyclin synthesis, the renin-aldosterone axis and catecholamines in patients with cardiac insufficiency].
    Gandini R; Baggio E; Pozzoli G; Massari D; Megali R; Vargiu B; Maraffi F; Assereto R; Montella S
    Cardiologia; 1989 May; 34(5):447-53. PubMed ID: 2758447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cardicap treatment of ischemic heart disease in aged patients].
    Zaslavskaia RM; Goncharov LF; Reshniak LM
    Klin Med (Mosk); 1997; 75(1):36-7. PubMed ID: 9082056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [4 different nitrate preparations with regard to the possible development of tolerance in long-term treatment].
    Mertens HM; Ohlmeier H; Mannebach H; Kabelitz K; Gleichmann U
    Herz; 1985 Jun; 10(3):172-81. PubMed ID: 3926614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.